TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
INVA

Innoviva Inc

Healthcare · Biotechnology

20.50$ -0.2% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Innoviva Inc (INVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 52 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow INVA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
44 33 37 44 49 59 49 44 50 55 35 52 191
6.5 6.5 6.4 6.4 10.0 6.5 6.5 6.5 6.6 70 10 10 97
1.4 1.3 1.5 1.6 1.6 1.7 2.1 2.4 2.4 16 2.6 4.7 26
17 -30 2.0 -14 2.0 3.0 2.9 -7.6 -8.6 -11 -14 -7.6 -42
0.2 0.2 0.0 0.0 0.3 4.0 0.0 0.0 1.1 1.1 0.5 0.4 3.2
-26 -5.2 -43 – -5.3 -15 -35 33 18 24 37 -55 24
– 0.1 – – – – – – – – – – –
-11 -15 -9.7 -5.2 0.0 0.0 -0.1 0.0 0.0 -4.6 -20 -31 -56
– – – – 0.0 0.0 – – – 0.0 – – –
-11 -15 -9.2 -5.1 0.2 0.6 0.2 1.2 11 -3.7 -20 -29 -42
7.0 14 -15 39 44 44 14 78 79 74 52 -33 173
44 33 37 44 48 55 49 44 49 53 35 52 188

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?